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Dear editor
Our team, general surgeons and gynecologists look constantly for ways to prevent 
postsurgical adhesions, and hence, we appreciate the platform you have established 
through multiple publications.1–3 This is especially because postsurgical adhesions 
may result in several complications such as the small bowel obstruction, secondary 
infertility, dyspareunia, chronic abdominal/pelvic pain and many others.
Prevention of postsurgical adhesions is still an unsolved problem in spite of the 
suggested modifications of current surgical methods and application of various barri-
ers, sprays, and use of other antiadhesive medications. We have already pointed out 
that a design of ideal nanoparticles should become a target of personalized adhesion 
prevention strategy in the future4,5 and therefore, we read with great interest the article 
by Shin et al that was recently published in your journal.6 This article explores the 
potential of postoperative adhesion prevention by nanofibers of poly(lactic-co-glycolic 
acid) (PLGA) loaded with epigallocatechin-3-O-gallate (EGCG), which is the most 
bioactive polyphenolic compound extracted from green tea.
The authors demonstrated that the effects of PLGA barrier loaded with EGCG 
in the prevention of adhesion are associated with the expression of its active com-
pound. EGCG possesses an antioxidant activity as well as a prolonged activated 
partial thromboplastin time (aPTT) as reported by in vitro experiments.6 The authors 
also demonstrated the significantly inhibited inflammation, neovascularization and 
fibrosis in animals treated with PLGA barrier loaded with EGCG compared with 
PLGA treatment only. In addition, the use of EGCG was associated with significantly 
reduced severity and extent of posttraumatic adhesions when compared with that of 
Interceed TC7.6
As we reported before, an increased severity of adhesion was associated with 
accelerated activation of spontaneous chemiluminescence (SCL) of peritoneal mac-
rophages (Figure 1). Two different adhesion barriers, TC7 with the size 0.3×3.5 cm 
(Ethicon Company, Johnson & Johnson) and Fibrin Glue (Beriplast, Behring, Ger-
many), applied on suture lines made during experimental surgery in an incised rat 
uterine horn were compared with similar lesions sutured using catgut 4/0 or prolene 
4/0 (Ethicon Company, Johnson & Johnson) without application of barriers.7,8 Peri-
toneal fluid was collected from the abdominal cavity of euthanized animals, and SCL 
patterns of freshly isolated macrophages were measured every day in three rats from 
each group. Changes in SCL were recorded and analyzed in comparison with the 
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Figure 1 Postsurgical spontaneous chemiluminescence activity of freshly isolated peritoneal macrophages (A) and adhesion severity (B) after application of two different 
adhesion barriers, tc7 with the size 0.3×3.5 cm (ethicon company, Johnson & Johnson) and Fibrin Glue (Beriplast, Behring, Germany), on suture lines made during 
experimental surgery in an incised rat uterine horn were compared with similar lesions sutured using catgut 4/0 or prolene 4/0 (ethicon company, Johnson & Johnson) 
without application of barriers.
Abbreviation: CI, confidence interval.
dynamic macroscopic and histological features of postsurgi-
cal acute inflammation, wound healing, and   adhesion forma-
tion, which were observed under the   transmission   electron 
microscopy. Experiments were done with the approval of 
the Institutional Local   Ethical committee (Academician V.I. 
Kulakov Research Center of Obstetrics, Gynecology, and 
Perinatology, Ministry of Health of Russia).7
In addition, we also found that there were reduced 
inflammation, neovascularization, and mild sclerotic 
changes after the application of both barriers7 as shown 
by Shin et al.6 Further studies evaluating the ability of 
EGCG to scavenge reactive oxygen species in peritoneal 
macrophages and cause prolonged activation of partial 
thromboplastin time in peritoneal fluid will enhance our 
current understanding of the related adhesion formation 
signaling pathways.
Acknowledgments
This work was supported by the Russian Science Foundation 
(grant no 14-31-00024).
Author contributions
All authors contributed toward data analysis, drafting and 
revising the paper and agree to be accountable for all aspects 
of the work.
Disclosure
The authors have no conflicts of interest or financial ties to 
disclose. The authors alone are responsible for the content 
and writing of the paper.
References
1.  Yang B, Gong C, Zhao X, et al. Preventing postoperative abdomi-
nal adhesions in a rat model with PEG-PCL-PEG hydrogel. Int J 
Nanomedicine. 2012;7:547–557.
2.  Gao X, Deng X, Wei X, et al. Novel thermosensitive hydrogel for pre-
venting formation of abdominal adhesions. Int J Nanomedicine. 2013;8: 
2453–2463.
3.  Wu Q, Li L, Wang N, et al. Biodegradable and thermosensitive micelles 
inhibit ischemia-induced postoperative peritoneal adhesion. Int J 
Nanomedicine. 2014;9:727–734.
4.  Mynbaev OA, Eliseeva MY, Malvasi A, Tinelli A. Challenging nano-
particles: a target of personalized adhesion prevention strategy. Int J 
Nanomedicine. 2014;9:3375–3376.
5.  Mynbaev OA, Eliseeva MY, Tinelli A, et al. A personalized adhe-
sion prevention strategy: Arslan E, Talih T, Oz B, Halaclar B, 
Caglayan K, Sipahi M. Comparison of lovastatin and hyaluronic acid/
carboxymethyl cellulose on experimental created peritoneal adhesion 
model in rats. Int J Surg. 12 (2) (2014) 120–124. Int J Surg. 2014;12(9): 
901–905.
6.  Shin YC, Yang WJ, Lee JH, et al. PLGA nanofiber membranes loaded 
with epigallocatechin-3-O-gallate are beneficial to prevention of post-
surgical adhesions. Int J Nanomedicine. 2014;9:4067–4078.
7.  Mynbaev OA. Etiology, pathogenesis and prevention principles of 
postoperative adhesions: ScD thesis. Moscow, 1997;45. Russian.
8.  Myinbayev OA, Rubliova KI. Use of chemiluminescent method for 
evaluation of postoperative adhesion formation after reproductive pelvic 
surgery: an experimental study. Am J Reprod Immunol. 1996;36(4): 
238–241.